We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Bio-Rad Laboratories Class A
BIO
$9.4B
| $34.1M | 0.08% |
69,483
-221,115
| -76% | -$115M |
|
327
Carrier Global
CARR
$52.4B
| $33.8M | 0.08% |
952,199
-469,297
| -33% | -$18.4M |
|
328
Yum! Brands
YUM
$40.1B
| $33.6M | 0.08% |
298,565
+2,506
| +0.8% | +$291K |
|
329
Goodyear
GT
$1.75B
| $33.6M | 0.08% |
3,179,418
+1,431,652
| +82% | +$17.9M |
|
330
Dolby
DLB
$5.8B
| $33.6M | 0.08% |
469,694
-139,879
| -23% | -$10.6M |
|
331
DXC Technology
DXC
$1.74B
| $33.6M | 0.08% |
1,139,990
+444,454
| +64% | +$13.8M |
|
332
Kennametal
KMT
$2.43B
| $33.3M | 0.08% |
1,471,040
+1,076,617
| +273% | +$28.3M |
|
333
Dentsply Sirona
XRAY
$2.36B
| $33.2M | 0.08% |
936,079
+388,388
| +71% | +$15.7M |
|
334
Ziff Davis
ZD
$1.99B
| $33.1M | 0.07% |
451,327
+81,982
| +22% | +$6.79M |
|
335
Union Pacific
UNP
$174B
| $33M | 0.07% |
157,067
+14,112
| +10% | +$3.21M |
|
336
Vontier
VNT
$4.69B
| $32.8M | 0.07% |
1,446,487
-54,959
| -4% | -$1.41M |
|
337
Johnson Controls International
JCI
$91.9B
| $32.8M | 0.07% |
685,994
-347,541
| -34% | -$19.4M |
|
338
National Fuel Gas
NFG
$7.71B
| $32.7M | 0.07% |
495,008
+21,005
| +4% | +$1.47M |
|
339
MSC Industrial Direct
MSM
$6.84B
| $32.6M | 0.07% |
440,089
+72,840
| +20% | +$5.98M |
|
340
Tapestry
TPR
$32.5B
| $32.4M | 0.07% |
1,082,048
+417,462
| +63% | +$13.7M |
|
341
Fair Isaac
FICO
$23B
| $32.3M | 0.07% |
82,032
+36,277
| +79% | +$14.3M |
|
342
Citizens Financial Group
CFG
$30.5B
| $32.2M | 0.07% |
921,289
+486,118
| +112% | +$19.2M |
|
343
PACCAR
PCAR
$69.7B
| $32.2M | 0.07% |
592,848
+171,709
| +41% | +$9.67M |
|
344
Zions Bancorporation
ZION
$10.2B
| $32M | 0.07% |
638,488
+74,601
| +13% | +$4.24M |
|
345
FNB Corp
FNB
$6.7B
| $31.6M | 0.07% |
2,952,095
+560,941
| +23% | +$6.55M |
|
346
Hewlett Packard
HPE
$73.1B
| $31.6M | 0.07% |
2,409,259
+1,505,584
| +167% | +$22.8M |
|
347
Fortinet
FTNT
$120B
| $31.4M | 0.07% |
557,908
-179,992
| -24% | -$10.7M |
|
348
Tractor Supply
TSCO
$17.9B
| $31.4M | 0.07% |
810,795
-377,065
| -32% | -$15.3M |
|
349
Baidu
BIDU
$37B
| $31.3M | 0.07% |
210,428
-248,385
| -54% | -$32.8M |
|
|
GRMN
350
Garmin
GRMN
$60.1B
| $31.2M | 0.07% |
321,015
-2,921
| -0.9% | -$308K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.